2022
Hepatectomy is associated with improved oncologic outcomes in recurrent colorectal liver metastases: A propensity-matched analysis
Sutton T, Wong L, Walker B, Dewey E, Eil R, Lopez C, Kardosh A, Chen E, Rocha F, Billingsley K, Mayo S. Hepatectomy is associated with improved oncologic outcomes in recurrent colorectal liver metastases: A propensity-matched analysis. Surgery 2022, 173: 1314-1321. PMID: 36435651, DOI: 10.1016/j.surg.2022.10.019.Peer-Reviewed Original ResearchConceptsColorectal liver metastasesPost-recurrence overall survivalRepeat hepatic resectionRecurrent colorectal liver metastasesHepatic resectionLiver metastasesSystemic treatmentOverall survivalIntrahepatic recurrenceOncologic outcomesSystemic therapyMedian post-recurrence overall survivalRetrospective single-institution cohort studySingle-institution cohort studyCurative-intent hepatectomyImproved oncologic outcomesPerioperative systemic therapyRelevant clinicopathologic variablesSignificant clinicopathologic differencesPropensity-matched analysisRole of resectionCox proportional hazardsLiver recurrencePerioperative chemotherapyCohort study
2013
Paradoxical significance of endorectal MRI (erMRI) response to neoadjuvant chemotherapy in patients with high-risk localized prostate cancer (HRLPC).
Galsky M, Xie W, Nakabayashi M, Ross R, Fennessy F, Tempany C, Choueiri T, Khine K, Kantoff P, Taplin M, Oh W. Paradoxical significance of endorectal MRI (erMRI) response to neoadjuvant chemotherapy in patients with high-risk localized prostate cancer (HRLPC). Journal Of Clinical Oncology 2013, 31: 23-23. DOI: 10.1200/jco.2013.31.6_suppl.23.Peer-Reviewed Original ResearchHigh-risk localized prostate cancerBiochemical recurrenceRadical prostatectomyPSA responseNeoadjuvant chemotherapyMedian time to biochemical recurrenceLikelihood of biochemical recurrenceTime to biochemical recurrenceAssociated with inferior outcomesResponse to neoadjuvant chemotherapyNeoadjuvant chemotherapy trialsPerioperative systemic therapyLocalized prostate cancerMedian Follow-UpMultivariate Cox regressionEndorectal MRINeoadjuvant trialsNeoadjuvant docetaxelSystemic therapyChemotherapy trialsProstate cancerErMRIClinical parametersInferior outcomesProliferative tumors
This site is protected by hCaptcha and its Privacy Policy and Terms of Service apply